컴퓨터 지원 탐지(CAD) 시장은 2024-2031년간 연평균 7.4%의 성장률로 2031년까지 15억 6,000만 달러에 달할 것으로 예측됩니다.
이 보고서는 광범위한 2차 및 1차 연구와 시장 시나리오에 대한 심층 분석을 통해 주요 시장 성장 촉진요인, 억제요인, 과제 및 기회 분석으로 구성되어 있습니다. 이러한 성장은 만성 질환의 유병률 증가, 조기 암 진단의 중요성에 대한 인식 증가, 암 연구에 대한 투자 및 자금 지원 증가, 의료비 증가에 기인합니다. 그러나 CAD 솔루션의 높은 비용은 이 시장의 성장을 억제하고 있습니다.
또한, 영상의학과 의사들 사이에서 CAD가 점점 더 많이 받아들여지고 있고, 암 검진 프로그램 증가, 인공지능(AI)과 머신러닝(ML)의 통합 등 CAD 솔루션의 발전은 이 시장에서 사업을 운영하는 기업들에게 성장 기회를 제공할 것으로 예상됩니다. 그러나 CAD 시스템 사용에 필요한 기술적 전문 지식의 부족은 시장 성장에 영향을 미치는 주요 과제입니다.
(주 : 주요 5개사의 SWOT 분석을 게재)
Computer-aided Detection (CAD) Market by Application (Oncology [Breast, Lung, Colorectal, Liver], Cardiology), Modality (Mammography, MRI, CT, Ultrasound), End User (Hospitals & Clinics, Imaging Centers, Ambulatory Care Centers) - Global Forecast to 2031
The Computer-aided Detection (CAD) market is projected to reach $1.56 billion by 2031 at a CAGR of 7.4% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the rising prevalence of chronic diseases, increasing awareness regarding the importance of early cancer diagnosis, increasing investments and funding for cancer research, and rising healthcare expenditure. However, the high costs of CAD solutions restrain the growth of this market.
Furthermore, the growing acceptance of CAD among radiologists, the increase in cancer screening programs, and advancements in CAD solutions, such as the integration of Artificial Intelligence (AI) and Machine Learning (ML), are expected to generate growth opportunities for the players operating in this market. However, the lack of technical expertise required to use CAD systems is a major challenge impacting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global Computer-aided Detection (CAD) market are Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), EDDA Technology, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Riverain Technologies (U.S.), Median Technologies (France), Agfa-Gevaert NV (Belgium), iCAD Inc. (U.S.), CureMetrix, Inc. (U.S.), and THERAPIXEL (France).
Among all the applications studied in this report, in 2024, the oncology segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the increasing prevalence of breast cancer and the increase in breast cancer detection and awareness campaigns. Breast cancer ranks among the most prevalent cancers affecting women globally. According to the World Health Organization (WHO), 2.3 million breast cancer cases were recorded globally in 2020, and this number is expected to reach 3 million by 2040. The rising incidence of breast cancer has led to a rapid increase in the adoption of innovative technologies, such as CAD, aimed at enhancing breast cancer detection through a combination of various modalities.
Among all the imaging modalities studied in this report, in 2024, the mammography segment is expected to account for the larger share of the Computer-aided Detection (CAD) market. Computer-aided mammograms offer improved accuracy in diagnosis as the images can be zoomed in on, upgraded, or adjusted for more in-depth evaluation. Also, computer-aided mammography enables early identification of breast cancer in patients with no symptoms. These factors contribute to the segment's large share.
Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the rising prevalence of cancer, the growing number of hospitals and clinics, the availability of highly skilled professionals in hospitals and clinics, the high purchasing power of hospitals, and the increasing patient population seeking comprehensive healthcare services, including diagnosis, treatment, and surgical procedures.
An in-depth analysis of the geographical scenario of the global Computer-aided Detection (CAD) market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the Computer-aided Detection (CAD) market. In the region in 2024, the U.S. is expected to account for the largest share of the Computer-aided Detection (CAD) market in North America. The large share of this regional market is attributed to the presence of major Computer-aided Detection (CAD) companies such as GE HealthCare Technologies Inc. (U.S.), and Hologic, Inc. (U.S.), increasing cancer cases, and technological advancements in cancer detection and diagnosis.
Computer-aided Detection (CAD) Market Assessment-by Application
Note: Other applications include neurology, diabetic retinopathy, and tuberculosis.
Computer-aided Detection (CAD) Market Assessment-by Imaging Modality
Note: Other imaging modalities include X-ray imaging and endoscopy.
Computer-aided Detection (CAD) Market Assessment-by End User
Computer-aided Detection (CAD) Market Assessment-by Geography
(Note: SWOT analyses of the top 5 companies will be provided.)